Fertomid 50mg Tablet

Fertomid 50mg Tablet

Fertomid 50mg Tablet is a high-potency pharmacological intervention containing Clomifene Citrate, a non-steroidal selective estrogen receptor modulator (SERM), specifically engineered for the clinical management of ovulatory failure and female infertility. Utilizing a unique “Neuro-Endocrine” delivery system, this formulation works by concurrently binding to estrogen receptors in the hypothalamus and pituitary gland, effectively neutralizing the biochemical triggers of negative feedback. By modulating the production of Gonadotropin-Releasing Hormone (GnRH), Fertomid increases the secretion of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of follicular development and promoting the successful release of an egg from the ovarian follicle.

Key Features

• Specifically formulated to block estrogen feedback at the hypothalamic level to stimulate natural ovulation.
• Clinically recognized for its role in promoting the growth and development of ovarian follicles.
• Specifically engineered to provide superior control over the timing of the ovulatory cycle.
• Acts as a functional catalyst to stabilize the release of FSH and LH from the anterior pituitary.
• Formulated to address infertility in women with ovulatory dysfunction, including those with PCOS.

Key Ingredients

• Clomifene Citrate (50mg)
• Lactose Monohydrate
• Maize Starch
• Magnesium Stearate

Precautions

• This is a high-potency hormonal medication. Use must be strictly monitored by an obstetrician or fertility specialist, including regular ultrasound monitoring.
• Contraindicated in patients with liver disease or a history of hepatic dysfunction.
• There is a clinically documented increased likelihood of multiple births (twins, triplets) associated with this therapy.
• Discontinue use immediately and consult a physician if blurring of vision or other visual symptoms occur during treatment.
• Not for use in patients with undiagnosed abnormal uterine bleeding, ovarian cysts (not related to PCOS), or thyroid/adrenal dysfunction.
• Keep the container tightly closed and store in a cool, dry place (below 25°C). Protect from direct light and moisture to prevent molecular degradation.

How to Use

• The tablet should be swallowed whole with a glass of water. Do not crush or chew the tablet to ensure intended systemic delivery.
• The standard introductory dose is typically 50mg daily, but the exact regimen must be specifically dictated by your healthcare professional.
• For optimal clinical results, administration typically begins on the 5th day of the menstrual cycle and continues for 5 consecutive days.
• Maintain a consistent daily schedule during the 5-day cycle to ensure stable systemic levels of the active constituent.
• Ovulation typically occurs 5 to 10 days after the final dose of the cycle. Tracking basal body temperature or using ovulation kits is recommended.
• If pregnancy is not achieved after the first cycle, the dosage and duration may be adjusted by your specialist for subsequent attempts.

Legal Disclaimer: Fertomid 50mg Tablet is a specialized fertility intervention. Individual results vary based on the patient’s baseline hormonal profile and underlying reproductive health. This product is for use under professional medical guidance only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.